Enhancing Type 2 Diabetes Treatment Through C-Peptide Assessment

Key Points

• To explore the impact of C-peptide assessment on treatment for Type 2 diabetes.
• Conducted assessments of C-peptide levels in patients with T2DM.
• Evaluated treatment response based on C-peptide levels seen in patients.
• Applied statistical analyses to determine treatment outcomes.
• C-peptide assessment shows significant improvements in glycemic control.
• Participants with monitored C-peptide levels demonstrate better treatment adherence.